(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.07%) $0.927
(0.30%) $10.87
(0.07%) $0.793
(-0.33%) $92.27
Live Chart Being Loaded With Signals
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer...
Stats | |
---|---|
Today's Volume | 144 260 |
Average Volume | 657 883 |
Market Cap | 124.69M |
EPS | SEK0 ( 2024-02-19 ) |
Next earnings date | ( SEK0 ) 2024-05-07 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -2.34 |
ATR14 | SEK0.00900 (1.17%) |
Volume Correlation
Isofol Medical AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Isofol Medical AB (publ) Correlation - Currency/Commodity
Isofol Medical AB (publ) Financials
Annual | 2023 |
Revenue: | SEK721 000 |
Gross Profit: | SEK-41.88M (-5 808.04 %) |
EPS: | SEK-0.230 |
Q4 | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-1 000.00 (0.00 %) |
EPS: | SEK-0.0550 |
Q3 | 2023 |
Revenue: | SEK-1 000.00 |
Gross Profit: | SEK-111 000 (11 100.00 %) |
EPS: | SEK-0.0400 |
Q2 | 2023 |
Revenue: | SEK361 000 |
Gross Profit: | SEK14 000.00 (3.88 %) |
EPS: | SEK-0.0466 |
Financial Reports:
No articles found.
Isofol Medical AB (publ)
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators